Pharma Journalist -

Disc Medicine, Inc. announced that is has entered into an agreement with Mabwell Therapeutics to obtain an exclusive license to a portfolio of monoclonal antibodies targeting TMPRSS6…
Read More...

Oerth’s unique PROTAC protein degradation technology is expected to be a new, game-changing generation of more sustainable crop protection products / The agreement recommits to the…
Read More...

Evaxion Biotech A/S announced that the U.S. Food and Drug Administration (“FDA”) has granted fast track designation for the Company’s personalized cancer therapy, EVX-01, in combination…
Read More...

BeiGene announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorizations for BRUKINSA (zanubrutinib) in Great Britain for both the…
Read More...

Advaxis, Inc., a biotechnology company devoted to the discovery, development and commercialization of immunotherapies based on a technology which uses engineered Listeria monocytogenes …
Read More...

Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or associated companies, "Sun Pharma") and Concert Pharmaceuticals, Inc. announced that they have executed a…
Read More...

EVOQ Therapeutics announced the advancement of their ongoing license and collaboration agreement with Amgen for the discovery and development of novel therapeutics including the receipt…
Read More...

Avidity Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AOC 1020 for the treatment of facioscapulohumeral muscular…
Read More...

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner SK bioscience has…
Read More...

APRINOIA Therapeutics Inc. ("APRINOIA"), a clinical-stage biotechnology company focused on neurodegenerative diseases such as Alzheimer's Disease ("AD") and Progressive Supranuclear…
Read More...